🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

VIVS VIVS

Company Profile ↓
$0.36
-80.35% 1Y
Mkt Cap$1.04M
P/E-0.07
P/B-0.95
52W High$4.78
52W Low$0.33
Book Value$-0.38
EPS (TTM)$-5.35

Company Overview

VIVS (VIVS) is a publicly traded company listed on with a market capitalization of $1.04M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Recent Developments

  • Mar 2026 Revenue of $131.00K (-9.0% YoY); net profit $-13.84M.
  • Trailing 12 Months Year-on-year growth — revenue -9.0%.
  • 5-Year Trend Long-term compounding — revenue CAGR -14.3%.

Growth & Price Performance

Compounded Sales Growth

5 Years:-14.27%
1 Year:-9.03%

Stock Price Performance

1 Year:-80.35%
6 Months:-86.78%
3 Months:-74.40%
1 Month:-59.61%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 1% of range
$0.33 $4.78
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)26.09 · Oversold
Price Performance
1M-59.61%
3M-74.40%
6M-86.78%
1Y-80.35%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

No notable strengths flagged.

CONS

  • Revenue declined at -14.3% CAGR over 5 years.
  • Trading 92.4% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-0.07
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-0.38
Price to Book
-0.95
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
-14.27%
Profit 5Y
-
Revenue (YoY)
-9.03%
Earnings (YoY)
-

Profitability & Returns

ROCE
-
ROE
-
ROA
-
Profit Margin
-
Op Margin
-
Gross Margin
100.00%
EPS (Latest Qtr)
$-1.03
EPS (TTM)
$-5.35

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
2.38
Current Ratio
2.38
Debt
$447.00K
Total Assets
$7.39M
Current Assets
$6.63M
Working Capital
$3.84M

Ownership

Promoter Holding
2.70%
Chg in Prom Hold
-
FII / Inst Holding
1.66%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$131.00K
EBITDA
$-13.61M
Free Cash Flow
$-10.83M
Operating Cash Flow
$-10.83M
Shares Outstanding
2.89M
Gross Margin
100.00%
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Dec 2014Mar 2015Jun 2015Sep 2015Dec 2015Mar 2016Jun 2016Sep 2016Dec 2016Mar 2017Jun 2017Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Jun 2019Sep 2019Dec 2019Jun 2020Sep 2020Dec 2020Jun 2021Sep 2021Dec 2021Jun 2022Sep 2022Dec 2022Jun 2023Sep 2023Dec 2023Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue ----------990.00K1.35M1.15M-689.00K943.00K779.00K668.00K1.23M298.00K000-00077.00K131.00K75.00K05.00K39.00K30.00K-51.00K37.00K28.00K26.00K40.00K
Cost of Revenue -----------------------------------00000
Gross Profit -----------------------------------51.00K37.00K28.00K26.00K40.00K
Operating Expenses -----------------------------------3.21M2.95M2.66M2.78M3.23M
Operating Income -6.96M--8.46M-11.28M-10.47M--8.78M-9.48M-9.63M--10.20M-9.58M-7.91M--7.58M-6.01M-6.53M-6.52M-6.83M-5.23M-2.79M-8.95M-2.49M-2.56M-3.51M-3.50M-3.24M-3.35M-3.36M-4.20M-4.12M-3.68M-3.39M-2.61M--3.15M-2.92M-2.63M-2.75M-3.19M
EBITDA -----------------------------------6.92M-2.78M-2.48M-2.63M-5.72M
Interest Expense -----------------------------------5.00K4.00K04.00K4.00K
Pretax Income -----------------------------------6.85M-2.84M-2.54M-2.69M-5.76M
Tax Provision -----------------------------------002.00K00
Net Income -6.99M-7.80M-8.49M-11.26M-10.46M-8.37M-8.77M-9.44M-9.58M-10.66M-10.10M-9.46M-7.79M-7.45M-7.42M-5.84M-6.40M-6.32M-6.29M-3.37M-2.77M-8.95M-2.51M-2.53M-3.50M-3.50M-3.21M-3.32M-3.26M-4.03M-3.99M-3.60M-3.34M-2.55M-6.85M-2.84M-2.54M-2.69M-5.76M
Diluted EPS ------------------------0.29-0.40-0.40-0.37-0.38-0.37-0.46-0.46-0.40-2.74-1.68-2.28--1.14-0.98-1.03-
R&D Expense 3.24M-4.14M4.74M4.59M-4.44M4.54M5.02M-5.03M4.94M4.00M-3.38M3.19M3.78M3.82M1.45M145.00K028.00K402.00K580.00K679.00K926.00K1.02M1.23M1.19M1.67M1.33M1.43M1.40M984.00K1.78M-1.00M923.00K1.14M-

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 969.00K1.20M379.00K571.00K1.48M4.23M4.60M3.09M2.20M0-370.00K109.00K144.00K131.00K
Cost of Revenue ------------05.00K0
Gross Profit ------------109.00K139.00K131.00K
Operating Expenses -----------18.10M15.20M12.76M11.62M
Operating Income -2.31M-9.32M-20.65M-30.30M-38.64M-38.58M-35.27M-27.27M-21.48M-16.83M--17.73M-15.09M-12.62M-11.49M
EBITDA ------------17.44M-14.39M-2.21M-13.61M
Interest Expense ------------010.00K12.00K
Pretax Income ------------17.26M-14.67M-2.49M-13.84M
Tax Provision -----------2.00K2.00K2.00K2.00K
Net Income --43.55M-25.85M-30.08M-38.58M-38.45M-34.80M-26.64M-18.71M-16.83M--17.26M-14.67M-2.49M-13.84M
Diluted EPS -0.19-0.97----------23.76-19.25-1.70-5.35
R&D Expense 1.42M3.44M7.97M12.92M18.01M19.55M17.96M14.75M5.28M1.10M3.32M8.88M5.50M5.03M4.19M

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2008Dec 2009Dec 2010Dec 2011Mar 2012Dec 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Dec 2024Mar 2025Mar 2026
Total Assets ---1.41M-16.75M17.38M50.19M53.49M67.58M69.18M49.83M40.62M28.44M39.92M-20.31M6.35M-14.65M7.39M
Current Assets ----------------17.05M3.94M-12.13M6.63M
Cash & Equivalents --285.00K340.00K10.35M14.82M15.63M48.17M50.14M62.09M62.75M43.73M36.48M27.36M37.36M-15.30M2.90M-11.31M5.02M
Inventory ----------------0297.00K-0-
Receivables ----------------152.00K33.00K-30.00K32.00K
Total Liabilities ---3.24M-22.05M8.41M1.90M4.79M5.39M6.82M5.24M4.33M1.81M721.00K-4.98M2.75M-4.16M8.48M
Current Liabilities ---1.98M-22.04M8.38M1.89M4.76M4.49M6.01M4.66M3.74M1.81M721.00K-3.67M1.86M-3.74M2.79M
Long Term Debt ---------------------
Total Debt ----------------1.80M1.39M-942.00K447.00K
Total Equity -96.00K-966.00K-2.30M-1.83M--5.30M8.97M48.28M48.70M62.18M62.36M44.59M36.30M26.63M39.20M-15.33M3.60M364.00K10.49M-1.10M
Shares Outstanding ----------------726.41K839.81K-1.90M2.89M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow -1.91M-9.69M-15.56M----28.86M-20.38M-14.88M-13.32M--12.41M-14.65M-9.46M-10.83M
Investing Cash Flow -111.00K-445.00K-----292.00K-76.00K747.00K-393.00K--966.00K816.00K9.03M94.00K
Financing Cash Flow 2.08M24.61M----10.11M13.15M4.93M23.84M-01.44M8.85M4.45M
Capital Expenditure -46.00K-357.00K-277.00K-1.52M-2.11M-1.35M-226.00K-79.00K-0-405.00K-409.00K-396.00K-42.00K-13.00K-
Free Cash Flow -1.96M-10.05M-15.84M----29.08M-20.45M-14.88M-13.73M--12.80M-14.70M-9.47M-10.83M
Net Change in Cash ------------13.37M-12.40M8.41M-6.29M
Share Buybacks --------01.00K0----

Ratios (Annual)

Figures in %.

Metric Dec 2011Dec 2012Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % ------------100.0%96.5%100.0%
Operating Margin % -237.9%-778.5%-5,448.3%-5,306.0%-2,605.7%-911.9%-766.3%-882.4%-977.9%---4,792.2%-13,840.4%-8,761.1%-8,768.7%
Net Margin % --3,638.5%-6,820.1%-5,268.3%-2,601.1%-908.9%-756.1%-861.7%-852.0%---4,664.6%-13,459.6%-1,727.8%-10,567.2%
ROE % -821.3%-53.5%-61.8%-62.0%-61.7%-78.1%-73.4%-70.3%-42.9%--112.6%-407.4%-23.7%1,259.6%
ROCE % 405.8%176.3%-42.8%-62.2%-61.3%-61.1%-78.1%-73.9%-80.6%-42.9%--106.5%-336.1%-115.6%-249.7%

Shareholding Pattern

Insiders
2.70%
Institutions
1.66%
Public Float
1.71%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for VIVS

Google News ue, 21 Jul 2026

Two Chinese firms place VivoSim's first paid mainland orders - Stock Titan

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxQNXBHaThBZGdMSGt1NXpXUldFaExNNFRJTWFoc1puNjkwYTdYb2p4M0RHQXVyZ0ZBNV9TUHZtOXhzMHhjU1lDN0t2NUdkSzhOcG1NR09Eall4UUFqVjJlb2J1UnY2QjFGZnpfZjhOaWpyU1o0emNjVlZYZEVrc281OFdiaUQ5bXhrdXUwYX…

Google News hu, 05 Mar 2026

Why Is VIVS Stock Up 79% Today? - Stocktwits

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxNdFJTaWpENUhtY25fZ2QyRTlEb093QTBMV1ZNYXAtN09xSm4xallBaHI1dGV6VDVOT1I3N3JwZ3kycm1DNGRHQmx4aWJLSGhfVDBtRXBJU0pXRkJGZE1MRnlNUGpZTk1yZWt6cXBZRWFXT2QwVGR3R0NmZlF0RTM1MUhCc3dGaDJxWHlkZG…

Google News hu, 16 Jul 2026

VivoSim Labs Announces $4.0 Million Private Placement with Institutional Investor and Warrant Amendment - Quiver Quantitative

<a href="https://news.google.com/rss/articles/CBMi1AFBVV95cUxNNnFJNm5wY1M3enNSODNja2h6REZxSTF2WnVPY3UyLVpKTEdUa0JrN2p0SmZIWjR1TkpaM0xfZWNMMVpmSU1LMk54S3BCaU03bUZwVmJfS3dpejlFdGZjemxqaHNySmV1UU9EYlBWUHhkalNWX0h2VURoOE1TY3VQV2NuS0JjU1k0SmpjRE…

Google News Mon, 03 Aug 2026

IPO Databook: VivoSim Labs (VIVS US) - Jul 2026 - Smartkarma

<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxOQW9kRldLajcwTEF1TUUzV3R3dnpzcGEtVk5UblR5NjVLbTh1ZVVIVkI4QXFGU2ZNRm5XTU1ic1ZfaFlvVV9YRkg2emc3dk9EYk9ab2NyaDJnU0NJMGpRNGdtWTM0Q05PcTZPZFhoRFR0b29Vd0ZhZXNadXRiZm5IUmNFNVA?oc=5" targ…

Google News Wed, 15 Jul 2026

Why Vivosim Labs Shares Are Rocketing on Wednesday? - Benzinga

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxQNjVMdkFabElrVWFpUS1WZWg1eHh0WFJ5QUF5bUFZcVVUVHF5bEtQTXRpM3Z6N0hjRUhRN19KV2wtZEotSV9HTkwtQzlvNmt2UEoza3dmMWpHT3B4V1VSQXZ6XzJNNWU5UjhpaEZlbDlqS3lMRS1hV1R0NEtfS2IzMjgyODUyekdnckNYNk…

Google News Mon, 27 Jul 2026

VivoSim Labs, Inc. Revenue Breakdown – NASDAQ:VIVS - TradingView

<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTE1IUm1rbXlwM3lWdzA4M0I1bnNwQ2RYdU5EdFN3em5kYlhIa2JMT2N3RmhmV2VWQzNKZ2MzRzkzaXhsUnEyUllvcUhrTUZEU21KV0pwVFEtaExmUFJ0N2lXanBicGdrOGhVQVBvOUJybmpkT0FRNG5Z?oc=5" target="_blank">VivoSim…

VIVS — Frequently Asked Questions

What is the current share price of VIVS?

As of 2026-08-05 17:25 PDT, VIVS trades at $0.36 on NASDAQ/NYSE. Its 52-week range is $0.33 to $4.78.

What is the market capitalisation of VIVS?

VIVS has a market capitalisation of $1.04M on NASDAQ/NYSE.

What is the P/E ratio of VIVS?

VIVS trades at a trailing price-to-earnings (P/E) ratio of -0.07. Its price-to-book (P/B) ratio is -0.95.

Is VIVS a good stock to buy?

This page provides a data-driven analysis of VIVS, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space